Search research articles
Contact Us
Filters
Showing results (81-90 of 94) with videos related to
Page
of 10
Sort By:
FEBS Letters
|
May 19, 2004
The steroid receptor RNA activator is the first functional RNA encoding a protein
S Chooniedass-Kothari, E Emberley, M K Hamedani, et al.
The American Journal of Pathology
|
December 14, 1999
Psoriasin (S100A7) expression and invasive breast cancer
S Al-Haddad, Z Zhang, E Leygue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2001
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma
S K Chia, C C Wykoff, P H Watson, et al.
British Journal of Cancer
|
April 16, 2002
The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer
K J Turner, J P Crew, C C Wykoff, et al.
British Journal of Cancer
|
April 3, 2003
Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma
P H Watson, S K Chia, C C Wykoff, et al.
The American Journal of Pathology
|
March 10, 2001
Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast
C C Wykoff, N Beasley, P H Watson, et al.
Cancer Research
|
June 30, 2001
Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density
N J Beasley, C C Wykoff, P H Watson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2013
Expression of both estrogen receptor-beta 1 (ER-β1) and its co-regulator steroid receptor RNA activator protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with estrogen receptor-alpha (ER-α)-negative early breast cancer (EBC)
Y Yan, X Li, A Blanchard, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 12, 1999
Comparison of the biochemical responses to human parathyroid hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans
L J Fraher, R Avram, P H Watson, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
November 10, 2006
Potential role of estrogen receptor alpha (ERalpha) phosphorylated at Serine118 in human breast cancer in vivo
Leigh C Murphy, G E Weitsman, G P Skliris, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 94) with videos related to
Sort By:
Page
of 10
FEBS Letters
|
May 19, 2004
The steroid receptor RNA activator is the first functional RNA encoding a protein
S Chooniedass-Kothari, E Emberley, M K Hamedani, et al.
The American Journal of Pathology
|
December 14, 1999
Psoriasin (S100A7) expression and invasive breast cancer
S Al-Haddad, Z Zhang, E Leygue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2001
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma
S K Chia, C C Wykoff, P H Watson, et al.
British Journal of Cancer
|
April 16, 2002
The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer
K J Turner, J P Crew, C C Wykoff, et al.
British Journal of Cancer
|
April 3, 2003
Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma
P H Watson, S K Chia, C C Wykoff, et al.
The American Journal of Pathology
|
March 10, 2001
Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast
C C Wykoff, N Beasley, P H Watson, et al.
Cancer Research
|
June 30, 2001
Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density
N J Beasley, C C Wykoff, P H Watson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2013
Expression of both estrogen receptor-beta 1 (ER-β1) and its co-regulator steroid receptor RNA activator protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with estrogen receptor-alpha (ER-α)-negative early breast cancer (EBC)
Y Yan, X Li, A Blanchard, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 12, 1999
Comparison of the biochemical responses to human parathyroid hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans
L J Fraher, R Avram, P H Watson, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
November 10, 2006
Potential role of estrogen receptor alpha (ERalpha) phosphorylated at Serine118 in human breast cancer in vivo
Leigh C Murphy, G E Weitsman, G P Skliris, et al.
Page
of 10